The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Janssen; Karyopharm Therapeutics; Kite/Gilead; MorphoSys; Novartis; TeneoBio
Speakers' Bureau - AstraZeneca; BeiGene; Epizyme; MorphoSys
Research Funding - Merck (Inst); Merck (Inst)
Outcomes in ZUMA-5 with axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) who had the high-risk feature of progression within 24 months from initiation of first anti-CD20–containing chemoimmunotherapy (POD24).
 
Caron A. Jacobson
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; precision biosciences
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Lonza; Nkarta; Novartis; Precision Biosciences
Speakers' Bureau - Axis Bioservices; Clinical Care Options
Research Funding - Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Kite/Gilead; Novartis; Precision Biosciences
 
Julio C. Chavez
No Relationships to Disclose
 
Alison Sehgal
Research Funding - Gilead Sciences; Juno/Bristol-Myers Sqibb; Kite, a Gilead Company
 
Basem M. William
Consulting or Advisory Role - Celgene; Guidepoint Global; Kyowa Hakko Kirin; miRagen; Navicor; Triangle Insights Group
Research Funding - Dova Pharmaceuticals; Incyte; Innate Pharma; Kite/Gilead; Merck; miRagen
 
Javier Munoz
Honoraria - Kyowa Hakko Kirin; Seagen
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Fosun Kite; Genentech; Gilead Sciences; Innovent Biologics; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Abbvie/Genentech; Acrotech Biopharma; AstraZeneca; Bayer; BeiGene; BeiGene; Celgene; Gilead Sciences; Kite, a Gilead company; Kyowa Hakko Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Celgene; Genentech/Abbvie; Incyte; Kite, a Gilead company; Millennium; Pharmacyclics/Janssen; Portola Pharmaceuticals; Seagen
 
Gilles A. Salles
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche/Genentech
Consulting or Advisory Role - Alimera Sciences; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Epizyme; Genmab; Genmab; Gilead Sciences; Incyte; Janssen; Miltenyi Biotec; morphosys; Novartis; Roche/Genentech; Velosbio
 
Carla Casulo
Honoraria - Gilead Sciences
Research Funding - Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Pashna N. Munshi
Honoraria - Incyte; Kite, a Gilead Company
Speakers' Bureau - Incyte; Kite, a Gilead Company
 
David G. Maloney
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech/Roche; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Legend Biotech; MorphoSys; Novartis; Pharmacyclics
Consulting or Advisory Role - A2 Biotherapeutics
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.
 
Sven De Vos
No Relationships to Disclose
 
Ran Reshef
Consulting or Advisory Role - Atara Biotherapeutics; Bristol-Myers Squibb; Gilead Sciences; Novartis; TScan Therapeutics
Research Funding - Astellas Pharma (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); immatics (Inst); Incyte (Inst); Pharmacyclics (Inst); Precision Biosciences (Inst); Shire (Inst); Takeda (Inst)
 
Lori Ann Leslie
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; Kite/Gilead; TG Therapeutics
Speakers' Bureau - AstraZeneca; BeiGene; Celgene; Epizyme; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Seagen; TG Therapeutics
 
Ibrahim Yakoub-Agha
Honoraria - Celgene; Kite, a Gilead Company; Novartis
 
Olalekan O. Oluwole
Consulting or Advisory Role - Bayer; Curio Science; Kite/Gilead; Legend Biotech; Pfizer; Spectrum Pharmaceuticals
 
Henry Chi Hang Fung
Honoraria - AbbVie; Amgen; AstraZeneca; Celgene/Bristol-Myers Squibb; Incyte; Janssen; Karyopharm Therapeutics; Kite, a Gilead Company; Pfizer; Sanofi; Takeda
 
Vicki Plaks
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Honoraria - Kite, a Gilead Company
Patents, Royalties, Other Intellectual Property - Genentech
Expert Testimony - Kite, a Gilead Company
 
Yin Yang
Employment - Kite, a Gilead Company
 
Jennifer Lee
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Mauro P. Avanzi
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences; Kite, a Gilead Company
Honoraria - Kite, a Gilead Company
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center; NYBC
Travel, Accommodations, Expenses - Gilead Sciences
 
Sattva Swarup Neelapu
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences
Consulting or Advisory Role - Adicet Bio; Alimera Sciences; Bristol-Myers Squibb; Calibr; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy; Royalty income from Takeda Pharmaceuticals
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics